High Homocysteine: What It Means for Your Heart
Homocysteine is an amino acid your body clears with the help of folate, vitamin B12 and vitamin B6. A high level tells you something about those vitamins and your kidneys. What it tells you about your heart is less than it first appears.
Elevated homocysteine, above 15 µmol/L, is linked with more heart disease and stroke, but it is a marker of risk, not a proven cause. Trials that lowered homocysteine with folic acid, B6 and B12 (VISP, HOPE-2 and NORVIT) did not cut their main cardiovascular outcomes. A 2017 Cochrane review found no effect on heart attacks and a small drop in strokes. A high result is a reason to check B12, folate and kidney function, and to look hard at LDL, blood pressure and smoking. FixFirst flags homocysteine above 10 µmol/L as borderline and above 15 as elevated, and reads it next to your B12, folate, eGFR and LDL.
Homocysteine levels: what counts as high
These are the tiers FixFirst applies to a homocysteine result. Your lab prints its own range too, so read the number against both.
| Homocysteine (µmol/L) | How FixFirst reads it | What it means |
|---|---|---|
| 10 or below | Not flagged | Within the range FixFirst treats as normal. |
| Above 10 to 15 | Borderline | Check B12, folate and kidney function before reading anything into it. |
| Above 15 | Elevated | Hyperhomocysteinaemia. Linked with more heart disease and stroke in observational studies. |
Some labs report mg/L. FixFirst converts it (1 mg/L ≈ 7.4 µmol/L).
How homocysteine relates to heart disease and stroke
The Homocysteine Studies Collaboration pooled 30 studies in a 2002 JAMA meta-analysis. In the prospective studies, after adjusting for known risk factors, a 25% lower usual homocysteine level (about 3 µmol/L) went with an 11% lower risk of ischaemic heart disease and a 19% lower risk of stroke. That is a modest association, not a large one.
Association is not cause. People with high homocysteine also tend to have lower B-vitamin intake and poorer kidney function, so the test of cause is to lower it and watch what happens. The trials below did that.
Homocysteine is not part of standard heart-risk scoring. The 2018 AHA/ACC cholesterol guideline lists risk-enhancing factors such as raised hs-CRP, Lp(a) and ApoB; homocysteine is not among them. LDL carries far more weight in that framework.
What happened when trials lowered homocysteine
Four large randomised trials and one Cochrane review. None showed that lowering homocysteine prevents heart attacks.
| Trial | Who took part | What they took | Cardiovascular result |
|---|---|---|---|
| VISP (Toole, JAMA 2004) | 3,680 adults after a non-disabling stroke | High-dose vs low-dose folic acid, B6 and B12 | No difference in recurrent stroke, heart events or death |
| HOPE-2 (Lonn, NEJM 2006) | 5,522 adults aged 55 or older with vascular disease or diabetes | Folic acid 2.5 mg, B6 50 mg and B12 1 mg vs placebo | No reduction in the combined rate of cardiovascular death, heart attack and stroke. Fewer strokes (relative risk 0.75) as a secondary result |
| NORVIT (Bønaa, NEJM 2006) | 3,749 people after a heart attack | Folic acid and B12, with or without B6, vs B6 alone or placebo | No benefit. A trend toward harm with the full three-vitamin combination (relative risk 1.22, 95% CI 1.00 to 1.50) |
| CSPPT (Huo, JAMA 2015) | 20,702 adults with high blood pressure in China, no prior stroke or heart attack | Enalapril plus folic acid 0.8 mg vs enalapril alone | 21% fewer first strokes (hazard ratio 0.79). No difference in heart attack |
| Cochrane review (Martí-Carvajal, 2017) | 15 trials, 71,422 people | B-vitamin homocysteine lowering vs placebo or low dose | No effect on heart attack or death from any cause. Stroke risk ratio 0.90 (95% CI 0.82 to 0.99) |
Only the stroke signal repeats (CSPPT, a HOPE-2 secondary result, Cochrane). It has not translated into any heart-attack benefit. The US has fortified grain with folic acid since 1998, so results from one population may not carry over to another.
What raises homocysteine
A high result usually has a correctable driver. These are the ones worth ruling out first.
What to do with a high homocysteine
Fix the drivers you can measure, then put heart-risk effort where trials show a payoff.
Frequently asked questions
What is a normal homocysteine level?
Does lowering homocysteine prevent heart attacks?
What causes high homocysteine?
Should I take B vitamins if my homocysteine is high?
Is homocysteine used to calculate heart disease risk?
How long does homocysteine take to come down?
References & Guidelines
- Homocysteine Studies Collaboration — Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis (JAMA 2002), PubMed
- Toole JF et al. — VISP randomized controlled trial (JAMA 2004), PubMed
- Lonn E et al. — Homocysteine lowering with folic acid and B vitamins in vascular disease, HOPE-2 (NEJM 2006), PubMed
- Bønaa KH et al. — Homocysteine lowering and cardiovascular events after acute myocardial infarction, NORVIT (NEJM 2006), PubMed
- Huo Y et al. — Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China, CSPPT (JAMA 2015), PubMed
- Martí-Carvajal AJ et al. — Homocysteine-lowering interventions for preventing cardiovascular events, Cochrane CD006612 (2017)
- Grundy SM et al. — 2018 AHA/ACC guideline on the management of blood cholesterol (Circulation 2019), PubMed
- Zhou Y et al. — Association between plasma homocysteine status and hypothyroidism: a meta-analysis (2014), PubMed
- NIH Office of Dietary Supplements — Folate fact sheet for health professionals
Homocysteine on your report?
Upload it and FixFirst ranks homocysteine next to your B12, folate, kidney markers and lipids, and moves it up if you report a family history of early heart disease.
Analyze My Blood Test →